Model-Observation Bridging Study (MOBS) for Ezetrol and Inegy

Trial Profile

Model-Observation Bridging Study (MOBS) for Ezetrol and Inegy

Phase of Trial: Phase IV

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs Ezetimibe (Primary) ; Ezetimibe/simvastatin (Primary) ; HMG-CoA reductase inhibitors
  • Indications Cardiovascular disorders; Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms MOBS
  • Sponsors Merck & Co; Merck Sharp & Dohme
  • Most Recent Events

    • 07 Jan 2016 No.of arms changed from 3 to 4 as per record.
    • 03 Dec 2014 Status changed from active, no longer recruiting to completed, as reported by record.
    • 01 Oct 2014 According to the record, planned end date changed from 1 Aug 2014 to 1 Oct 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top